SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-042909
Filing Date
2024-05-14
Accepted
2024-05-14 16:01:42
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205696-10q_longeveron.htm   iXBRL 10-Q 649688
2 CERTIFICATION ea020569601ex31-1_longeveron.htm EX-31.1 9547
3 CERTIFICATION ea020569601ex31-2_longeveron.htm EX-31.2 9914
4 CERTIFICATION ea020569601ex32-1_longeveron.htm EX-32.1 4962
10 GRAPHIC image_001.jpg GRAPHIC 1514
11 GRAPHIC image_002.jpg GRAPHIC 1570
12 GRAPHIC image_003.jpg GRAPHIC 1566
  Complete submission text file 0001213900-24-042909.txt   4669787

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lgvn-20240331.xsd EX-101.SCH 41069
6 XBRL CALCULATION FILE lgvn-20240331_cal.xml EX-101.CAL 36583
7 XBRL DEFINITION FILE lgvn-20240331_def.xml EX-101.DEF 257960
8 XBRL LABEL FILE lgvn-20240331_lab.xml EX-101.LAB 417305
9 XBRL PRESENTATION FILE lgvn-20240331_pre.xml EX-101.PRE 256792
76 EXTRACTED XBRL INSTANCE DOCUMENT ea0205696-10q_longeveron_htm.xml XML 437554
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40060 | Film No.: 24944099
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)